Patents Assigned to Transition Therapeutics Ireland Limited
  • Publication number: 20150306043
    Abstract: The invention relates generally to novel compositions and methods comprising a scyllo-inositol compound and one or both of valproic acid compound and lamotrigine. The compositions and methods provide beneficial effects in the treatment of bipolar disorders.
    Type: Application
    Filed: September 27, 2013
    Publication date: October 29, 2015
    Applicant: TRANSITION THERAPEUTICS IRELAND LIMITED
    Inventors: Susan ABUSHAKRA, Gerald CRANS, Ramon HERNANDEZ, Jesse CEDARBAUM
  • Patent number: 8889921
    Abstract: Methods of synthesis of scyllitol diborate and related compounds are provided, including methods that are performed in all-aqueous solutions. Also provided are methods in which the reaction products are recycled to increase the efficiency of the process. The methods include the steps of conversion of a solution of inositol to scyllitol, conversion of scyllitol in the solution to scyllitol diborate, and isolation of the scyllitol diborate from the solution. The scyllitol diborate is reacted to form substantially pure scyllitol diborate, and the remaining solution is efficiently recycled to scyllitol diborate, then to additional substantially pure scyllitol. This scyllitol diborate recycling step can be applied to a variety of processes to improve the yield of scyllitol. The methods are highly efficient and result in large scale reaction products of high purity.
    Type: Grant
    Filed: October 13, 2011
    Date of Patent: November 18, 2014
    Assignee: Transition Therapeutics Ireland Limited
    Inventor: Scott Greenfield